Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Early detection of Parkinson's disease through peripheral nerve changes

Studies a method to spot early Parkinson's-type disease in adults with nerve damage.

Plain-language title generated from the registry record
Registry title: Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System

Key facts

Where
Aarhus, DenmarkSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT06745011, who can take part

Where in Denmark

  • Institute of Clinical Medicine, Aarhus UniversityAarhus, DenmarkNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Aarhus
Trial code
NCT06745011
Record updated
8 January 2025
Original description
Description of a method to detect Parkinson's disease or Parkinson's-like disease at an early stage (Prodromal Parkinson's Disease) where damage is still confined to the peripheral nervous system damage. Simultaneous collection of biological material to establish a biobank for use as prognostic biomarkers for the development of Parkinson's disease and other neurodegenerative diseases in which pathological alpha-synuclein deposits accumulate.Read full original descriptionShow less

Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System

Description of a method to detect Parkinson's disease or Parkinson's-like disease at an early stage (Prodromal Parkinson's Disease) where damage is still confined to the peripheral nervous system damage. Simultaneous collection of biological material to establish a biobank for use as prognostic biomarkers for the development of Parkinson's disease and other neurodegenerative diseases in which pathological alpha-synuclein deposits accumulate.

Inclusion: Definite polyneuropathy without known etiology (idiopathic) AND orthostatic hypotension (active stand test) OR non-nocturnal blood pressure reduction (24 hour blood pressure measurement).

Exclusion: A diagnosis of either dementia, Parkinson's disease, Dementia with Lewy Bodies or Multiple System Atrophy; Known etiology of polyneuropathy.

ClinicalTrials.gov NCT06745011